To determine associations between MRI-lesions originating from either axial spondyloarthritis (axSpA) or from degeneration and pain in patients with chronic back pain of <2 years duration.
Introduction
Axial spondyloarthritis (axSpA) is a rheumatic disease characterized by inflammation of joints and entheses with predominantly spinal involvement 1 . Sacroiliitis on radiographs or magnetic resonance imaging (MRI) plays a role in the diagnostic process and as one of the entry criteria of the Assessment of SpondyloArthritis international Society (ASAS) classification criteria for axSpA 2 . Besides inflammation, MRI can also visualize structural lesions considered typical for axSpA like fatty lesions, erosions and excessive bone formation 3 . Although the MRI of the spine (MRI-spine) does not contribute to the ASAS criteria, it may visualize lesions rather typical for axSpA. However, MRI-spine can also depict degenerative changes, either occurring in isolation or in combination with lesions considered typical for axSpA. These degenerative changes are common in both symptomatic and asymptomatic populations 4 . Frequently patients present to the rheumatologist with back pain complaints of unknown origin. An important aim of the clinician is to find an explanation for the symptoms and to make a diagnosis. It is often hypothesized that MRI lesions due to axSpA will cause pain. In addition, MRI-spine is often included in the (diagnostic) imaging protocol to exclude other pathologies like degeneration, which may also explain pain reported by patients. For clinicians, it is relevant to know whether there is a true relationship between MRI lesions, either due to axSpA or to degenerative changes, and pain localized at the same site. Two previous studies investigated the possible association between the location of MRI lesions and site of pain 5, 6 . However none of these studies investigated this association in an early chronic back pain (CBP) cohort nor combined the data of axSpA associated lesions and degenerative lesions. Our objective was twofold: a) to evaluate if the presence of axSpA associated lesions seen on MRI of the sacroiliac joints (MRI-SI) is related to presence of buttock pain and b) if the presence of MRI-spine lesions typical for axSpA or for degenerative disease is related to CBP localized at the same site. This was executed in the SPondyloArthritis Caught Early (SPACE) cohort, comprising young patients with chronic back pain of relatively short duration of unknown origin, part of whom fulfil the ASAS classification criteria for axSpA.
Methods
Patients with CBP (≥3 months, ≤2 years, onset <45 years) of unknown origin were included in the SPACE cohort. Five participating centers in the Netherlands (Leiden, Amsterdam and Gouda), Norway (Oslo) and Italy (Padova) recruited patients of ≥16 years. At intake, all patients were asked to localize the sites of pain. Answering options were: thoracic and/or lumbar spinal segment, and/or buttock region. Patients were classified according to the ASAS axSpA classification criteria ('ASAS+' or 'ASAS-') 2 . The large majority of patients in the ASAS-group were labelled as having 'nonspecific back pain'. Recruitment details and the clinical assessment of the study population have been published previously 7 .
MRI assessment
MRI-SI and MRI-spine was performed on a 1.5T scanner with the acquired sequences T1-weighted and short tau inversion recovery (STIR) in coronal oblique (MRI-SI) and sagittal view (MRI-spine). Two trained readers scored axSpA lesions (MdH and PB) in the SI joints and spine and two other readers scored degenerative changes (FdB and LdB) in the spine, with both sequences viewed simultaneously. Readers were blinded for patient characteristics, clinical outcome and the scores of the other readers. When specific conditions arose adjudication scores were obtained (explained below).
AxSpA lesions
On MRI-SI, inflammatory lesions were scored according to the SpondyloArthritis Research Consortium of Canada (SPARCC) method. In this method, the presence of inflammation is scored as present/absent in each quadrant of the SI joint in 6 consecutive slices, which represent the larger part of the synovial compartment of the SI joints. In addition, scores for lesion intensity (brightness equal to spinal fluid or veins) and depth (homogeneous and unequivocal signal increase extending >1 cm for articular surface) were provided per quadrant 8 . With an adapted version of the SPARCC method structural MRI-SI lesions (fatty lesions, erosions, sclerosis and ankylosis) were scored according to the same procedure as inflammatory lesions 9 . Corner inflammatory and structural MRI-spine lesions (fatty lesions, erosions (vertebral corner erosions) and syndesmophytes) were scored in 23 vertebral units (VU) according to the Canada-Denmark score 10, 11 . Inflammatory and fatty lesions were scored when present on ≥2 consecutive slices. Erosions and syndesmophytes were scored when visible on ≥1 slice. In addition, readers gave a general dichotomous verdict about the MRI-SI (positive/negative), based on the following ASAS definition: ≥2 inflammatory lesions highly suggestive of axSpA on one slice or one lesion seen on ≥2 consecutive slices 12 . A dichotomous score of positive MRI-spine was based on the following ASAS definition: ≥3 corner inflammatory lesions each seen on ≥2 consecutive slices 13 . An adjudicator (RvdB) was introduced when readers disagreed on a positive MRI-SI or positive MRI-spine. If the primary readers agreed on a positive (or negative) MRI-SI, the mean SPARCC scores were calculated based on the scores of these primary readers. In case of disagreement, the mean scores were based on the consensus scores of the adjudicator and one primary reader. A similar process was followed for calculating the mean Canada-Denmark scores in the MRI-spine.
Degenerative lesions
We scored each VU for: disc degeneration using the Pfirrmann classification. This is a morphologic grading system, based on various stages of pathologic changes in the disc. Grade 1 is considered normal and grade 2 is 'any visual deviation of normal without signs of actual degeneration'. Therefore, a cut-off of >2 was used (as is customary in many other publications) 14, 15 . High intensity zone (HIZ): protrusion of the nucleus pulposus in the posterior element of the discus, resulting in a higher signal on STIR in the posterior part of the discus on MR imaging, hence the name 16, 17 . Herniation: projection of disc material outside the vertebral contour 17 . Schmorls' nodes: these are projection of disc material into the vertebral endplate, resulting in an indentation of the vertebral endplate [18] [19] [20] . Modic changes: Type I are reactive end plate changes with inflammation (seen as high signal on STIR images), type II are reactive endplate changes with fat deposition (resulting in high signal on T1 images) 21, 22 . In addition, we defined degenerative disc disease (DDD) as a degenerative complex with presence of disc degeneration and an HIZ and herniation together in an intervertebral disc 17, 18 . An adjudicator (MR) was introduced in case of disagreement between the readers for presence/absence of Modic changes, herniation, HIZ and Schmorls' nodes. For Pfirrmann classification, adjudication was performed if the difference between the 2 readers was 2 classes or more (if there was only a 1 class difference, the lowest class was used).
Statistical analysis
Separate analyses were performed for lesions found on MRI-SI and MRI-spine. The association between MRI-SI lesions and buttock pain was studied with a logistic regression model. First a univariable analysis was performed, followed by multivariable to adjust for potential confounders. Scores of lesions in the SI joints varied widely between patients and therefore continuous scores were used. For MRIspine, a multilevel model with generalized estimating equations (GEE) with an exchangeable correlation structure was used to investigate the association between the presence of each MRI-spine lesion separately and the occurrence of pain at the same site, taking both levels of the spine into account 23 . This analysis adjusts for spurious associations within patients presenting with lesions at different sites and provides the opportunity to interpret the effect of a lesion on pain as an independent effect of other investigated lesions. Since the majority of patients had a low score for spine lesions and only a few patients had a high score, dichotomous scores (presence/absence) were used. Interactions were tested to explore whether fulfilment of the ASAS axSpA-classification criteria, Human-Leukocyte-Antigen-B27 (HLA-B27) positivity, gender or age were possible effect modifiers. An interaction term with p<0.10 was a priori considered relevant. In case of a relevant interaction data were presented per subgroup (eg. for age, HLA-B27, gender). For age, strata based on tertiles were explored. All analyses were performed using Stata 13 and p-values <0.05 were considered statistically significant.
Results
There were 348 patients with available baseline MRI-spine and clinical data, and 342/348 patients also had available MRI-SI. Patients' mean age was 29.4 (SD 8.2) years, 36.2% (n=126) were men and 36.5% (n=127) fulfilled the ASAS classification criteria for axSpA. Of the 348 patients, 37.9% (n=132) were HLA-B27 positive; of the axSpA patients 87.4% (n=111) were HLA-B27 positive. All patients had back pain since this was an inclusion criterion for the study. Patients could localize their pain at multiple levels and 35.9% (n=125) of the patients indicated pain at the thoracic site, 82.5% (n=287) at the lumbar site and 57.8% (n=201) at the buttock site.
Interaction analyses showed that in the SI joints, an interaction with p<0.10 was found with age between buttock pain and sclerosis (β=-0.06; p=0.059) and erosions (β=-0.02; p=0.014). In the spine an interaction was found for age between pain and Modic type 1 lesions (β=0.14; p=0.025), and DDD (β=0.07; p=0.029), for sex between pain and HIZ (β=0.90; p=0.05), for HLA-B27 status: HIZ (β=-0.87; p=0.053), herniation (β=-0.84; p=0.016) and disc degeneration (β=0.25; p=0.096); for ASAS status: HIZ (β=-0.87; p=0.055) and herniation (β=-0.65; p=0.056). Table 1 showed that inflammatory lesions (20.8%) and erosions (29.2%) are found on MRI-SI in >20% of the patients, and fatty lesions on MRI-SI in 14.6% of the patients. Sclerosis and ankylosis on MRI-SI and axSpA lesions on MRI-spine were not very prevalent, occurring in 5-23 patients (1.4%-6.6%). Lesions were equally distributed among the thoracic and lumbar spine. In patients with lesions, inflammatory lesions in the SI joints had the widest range per patient; 0.5-53 (table 2) . In general, a wider range of lesions was seen on MRI-SI than on MRI-spine. In patients with axSpA spinal lesions, the number of lesions and range was higher in the thoracic than in the lumbar spine. For MRI-SI lesions, a significant association with buttock pain was found for inflammatory lesions (OR 1.06, p=0.038). Because of a significant interaction with age the data on erosions were provided for subgroups of age (<25 years, between 25 and 34 years, ≥35 years). Only in patients <25 a significant association was present (OR 1.16, p=0.04) (table 3) . While the interaction analysis reported age as a relevant effect modifier in the relation between sclerosis and pain, the subgroup associations were not statistically significant. There was no association between ankylosis and pain. Table 4 showed that none of the spinal axSpA lesions were significantly associated with pain. 
AxSpA lesions

Degenerative lesions
Degenerative lesions were not equally distributed among the thoracic and lumbar spine. Table 1 showed that Modic changes, DDD, HIZ, herniation and disc degeneration were more often seen in the lumbar than in the thoracic spine. Table 2 showed that in patients with at least one degenerative lesion, only a few patients had >1 lesions (median was 1) in both the thoracic and the lumbar spine. As expected, Schmorls' nodes (median=2, range 1-10) and disc degeneration (median=2, range 1-10) were more frequent in the thoracic spine and DDD (median=2, range 1-6) was more frequent in the lumbar spine (table 2) . HIZ was absent in the thoracic spine. For degenerative lesions, significant associations with pain were found for various lesions in specific subgroups. Splitting the population in age-tertiles yielded strongest associations for DDD and Modic type 1 lesions with pain in the upper tertile (patients aged ≥35 years), as shown in table 4. In stratified analyses, an association of HIZ with spinal pain was found in HLA-B27 negative (OR=2.88, p=0.001), ASAS-(OR=3.43, p<0.001) and female patients (OR=3.92, p<0.001). In addition, we further analysed these subgroups by stratifying on both ASAS status and gender and found the strongest association in ASAS-female patients (OR=5.09, p=0.001). Herniation was associated with pain in HLA-B27 negative and ASAS+ and ASAS-patients, but in the latter with a stronger relationship than in ASAS+ patients (OR range 1.45-4.66). To analyse disc degeneration and pain, patients were divided in an HLA-B27 positive and negative group. However, none of the subgroups showed significant associations between MRI-lesion and pain (table 4) . When analysing the complete group (n=348) the association between DDD and pain was statistically significant (OR=1.46; CI 1.07-1.96 (p=0.015)).
We analysed the overlap between the degenerative reading (the adjudicated scores) and the axSpA readings of the individual readers to ensure that the same lesion is not interpreted as degenerative and as axSpA. We found that in 7 VU (6 patients) inflammatory axSpA lesions and Modic type 1 lesions co-exist, based on the adjudicated scores of degeneration and axSpA reader 1 (6 VU in 4 patients for reader 2). No overlap has been found between the degenerative reading and the axSpA readings for co-existence between Modic type 2 and fatty lesions. HLA-B27-0.97 0.86 -1.09 0.59 ± Where a statistically and clinically relevant interaction was found, results are shown stratified for the variable(s) indicated in this column. Where no stratification is shown, it means that there was no relevant interaction with age, sex, HLA-B27 status or fulfilment of the ASAS axSpA criteria * P value < 0.05 § Analyses were stratified according to age tertiles
Discussion
In this study the relationship between site of lesions on MRI-SI or MRI-spine and the localization of pain by patients was investigated in patients presenting with chronic back pain between 16 and 45 years of short duration, with 36.5% patients fulfilling the ASAS axSpA criteria. We have found in the SI joints an association between inflammatory lesions and buttock pain as well as an association between erosions and buttock pain. To calculate the likelihood that a patient indicates buttock pain the OR of 1.06 should be multiplied for every inflammatory lesion present. As the median number of lesions per patient is 3 (with a range up to 53) this may result in a clinically (very) relevant association (e.g. for 3 inflammatory lesions an 19% increased risk). In patients younger than 25 years, the increased risk is 16% for a single erosion and 81% for 4 erosions (median number of erosions 3.5) present on MRI-SI. In addition, an association between several types of degenerative lesions but not with axSpA spinal lesions and pain was found in the spine. AxSpA lesions were not very prevalent in the spine of CBP patients with a maximum of two years symptom duration (<10% of patients), but were far more prevalent in the SI joints. Degenerative lesions were more prevalent in the lumbar spine than in the thoracic spine, with the exception of Schmorls' nodes.
To our knowledge there is one other study in which the relation between the localization of pain and axSpA lesions on MRI was investigated and the findings were partly matching the findings in our study. Like in the current study, Blachier et al. found an association between buttock pain and inflammatory and structural MRI-SI lesions, but with higher ORs of 2.86 and 1.89, respectively 5 . Unfortunately the readers in that study did not differentiate between structural lesions, so it is unclear what type(s) of structural lesion(s) were associated with buttock pain. Using logistic regression analysis, Blachier et al. also found the thoracic and lumbar pain site to be related to inflammatory lesions at the same site. Logistic regression analyses takes the site (lumbar vs thoracic) rather than the patient as the dependent variable, does not adjust for within-patient correlation and consequently may yield spurious correlations. This is why we have used GEE which adjusts for within-patient correlation. Different analysis methods may explain lower ORs in our study as compared to Blachier's. Moreover, a larger proportion of patients in the current study did not fulfil the ASAS criteria compared to Blachier et al. and thus, consequently subgroups of axSpA/AS associated interactions (ASAS status, HLA-B27 status and gender) were smaller. In addition, patients were enrolled in the SPACE cohort in an early stage of the disease, resulting in only few patients with lesions in the spine and in low numbers of lesions per patient who had at least one lesion. Moreover, the reading of the erosions and syndesmophytes was done by a 1-slice approach. This resulted in a difference in reading between the two readers: frequently a single erosion was scored by one reader but not by the other reader. This can be seen when comparing the low percentage of patients with erosive disease in table 1 and the average of the reader scores of 0.5 in at least 75% of the patients. The same applies to the syndesmophytes. The absence of a relation between erosions or syndesmophytes and pain is most likely due to the very low number of lesions in patients early in disease, but we cannot rule out that a discrepancy in reading between the readers played a role.
Modic type 1 lesions, herniation, HIZ and DDD showed the strongest association with pain in various subgroups. For DDD and Modic type 1 lesions, this association was strongest in the group of patients ≥35 (upper tertile). Obviously, these lesions are more common in the 'older' patient group, but it should be noted that the maximum age did not exceed 45 years. Expectedly, associations may even be stronger in older patients than those investigated in this cohort. For herniation and HIZ, associations with pain were found in the subgroups that are least associated with axSpA/AS: females, HLA-B27 negative patients and patients not fulfilling ASAS criteria. In contrast, disc degeneration seemed to be associated with pain in the entire group. Many other studies have confirmed the association between degenerative lesions and back pain. Kjaer et al. investigated a randomly selected sample of 413 40-year-old individuals from the general population 6 . The associations between the presence of various degenerative lesions in the lumbar spine and reported back pain during the previous 3 months, reported back pain during the last year, as well as reported back pain for which medical care was sought, were analysed. The 3 types of back pain, defined by Kjaer, were statistically significantly associated with Modic changes (ORs ranging from 1.9-4.2) and disc degeneration (ORs ranging from 1.5-2.6). HIZ were associated with back pain in the last year and back pain for which care was sought (ORs were 2.0 and 2.5 respectively), as was herniation with ORs 1.9 and 2.2. In a meta-analysis including data of 3097 patients from 14 studies, aged 50 at most, an association was found between back pain and disc degeneration (OR 2.24), herniation (OR 2.65) and Modic type 1 (OR 4.01) but not with HIZ 24 . We are not aware of studies that have analysed a complex of degenerative lesions comparable to the DDD as was used in the current study. As far as we know, no single study has investigated the association between degenerative changes and pain in a cohort of young patients referred and included with a certain suspicion of axSpA.
Degenerative changes on MRI are rather prevalent in otherwise asymptomatic patients 4, 25 , which makes it difficult to assume a causal relationship. On the other hand, the rather strong positive associations that we have found between MRI-signs of degenerative spine disease and back pain in patients with characteristics least associated with axSpA, as well as the regional co-localization of MRI-signs and symptoms, make us feel confident to hypothesize that -at least in the patients in our cohort, who experienced back pain almost daily for at least 3 months and sought help for that-the degenerative changes may indeed cause back pain at the same sites.
Our study has a few limitations. Due to the cross-sectional nature of our study, we were not able to analyse causality. Therefore, future analyses could focus on whether the lesions seen on MRI-SI and MRI-spine are 'site-stable' or that the site of MRI lesions may change over time with longitudinal analyses. It would be interesting to see whether the localization of pain will change when the site of MRI-lesions changes. Such a detailed analysis requires multiple well-trained readers, as was performed in this study, and also adjudication, in order to assure reliability of findings and a high level of internal validity. Needless to say that internal validity may go at the expense of generalizability: it will still be difficult to attribute localized pain in an individual patient to a site-specific lesion on MRI reported by a radiologist in usual clinical practice. Another possible limitation is the exclusion of the posterior elements. However, in an earlier analysis of this cohort, we found that inflammation in the posterior element was present in only 4% of the patients and this was always in patients who also have inflammation in the vertebral bodies 26 . This may be different in patients with more longstanding disease.
In conclusion, inflammatory lesions and erosions in the SI joints that are typical for axSpA are associated with buttock pain and degenerative lesions on MRI of the spine are associated with back pain in corresponding regions, especially in the subgroups of patients least associated with axSpA. No association was found between pain and axSpA lesions in the spine. 
